State of Tennessee, Department of Treasury’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-676
| Closed | -$704 | – | 1745 |
|
|
2024
Q3 | $704 | Sell |
676
-41
| -6% | -$43 | ﹤0.01% | 1715 |
|
|
2024
Q2 | $1.24K | Hold |
717
| – | – | ﹤0.01% | 1709 |
|
|
2024
Q1 | $1.71K | Sell |
717
-175
| -20% | -$418 | ﹤0.01% | 1681 |
|
|
2023
Q4 | $2.97K | Sell |
892
-37,080
| -98% | -$124K | ﹤0.01% | 1654 |
|
|
2023
Q3 | $142K | Sell |
37,972
-8,118
| -18% | -$30.4K | ﹤0.01% | 1530 |
|
|
2023
Q2 | $197K | Buy |
46,090
+7,925
| +21% | +$33.8K | ﹤0.01% | 1606 |
|
|
2023
Q1 | $261K | Sell |
38,165
-7,686
| -17% | -$52.6K | ﹤0.01% | 1494 |
|
|
2022
Q4 | $363K | Buy |
45,851
+791
| +2% | +$6.26K | ﹤0.01% | 1424 |
|
|
2022
Q3 | $433K | Buy |
45,060
+2,662
| +6% | +$25.6K | ﹤0.01% | 1363 |
|
|
2022
Q2 | $307K | Sell |
42,398
-361
| -0.8% | -$2.61K | ﹤0.01% | 1450 |
|
|
2022
Q1 | $552K | Buy |
42,759
+5,869
| +16% | +$75.8K | ﹤0.01% | 1370 |
|
|
2021
Q4 | $588K | Hold |
36,890
| – | – | ﹤0.01% | 1308 |
|
|
2021
Q3 | $594K | Sell |
36,890
-2,199
| -6% | -$35.4K | ﹤0.01% | 1316 |
|
|
2021
Q2 | $541K | Buy |
39,089
+850
| +2% | +$11.8K | ﹤0.01% | 1335 |
|
|
2021
Q1 | $559K | Buy |
38,239
+158
| +0.4% | +$2.31K | ﹤0.01% | 1295 |
|
|
2020
Q4 | $662K | Buy |
38,081
+1,955
| +5% | +$34K | ﹤0.01% | 1193 |
|
|
2020
Q3 | $662K | Buy |
36,126
+243
| +0.7% | +$4.45K | ﹤0.01% | 1081 |
|
|
2020
Q2 | $641K | Buy |
+35,883
| New | +$641K | ﹤0.01% | 1103 |
|